Total Funding
33
39
Total FundingSeed raised
Growth Score
-1 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
245471
Combined Therapeutics Inc. (CTx) is a pre-clinical-stage biotech in the game-changing segment of cancer research that is immunotherapy.
David Neafus: CFOPast Role: Triana Biomedicines, CFO- Romain Micol: President, Co-founder, and CEO
About the Company
Combined Therapeutics Inc. (CTx) is a pre-clinical-stage biotech in the game-changing segment of cancer research that is immunotherapy. The company is converging nanomedicine and biotechnology to enhance the tumoral cells and the tumoral microenvironment targeting. Combined Therapeutics Inc. (or CTx) is an immuno-oncology spin-out of the highly
successful and entrepreneurial Langer-Lab at the Massachusetts Institute of Technology (MIT). The first word of their name “Combined” emanates from the fact that they combine their technology with existing immuno-oncology products for a breakthrough in immunotherapy and better patients healthcare.
